BioNexus Gene Lab Corp Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2024 to Q2 2025
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
BioNexus Gene Lab Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2024 to Q2 2025.
- BioNexus Gene Lab Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 1.8M shares, a 1.69% increase year-over-year.
- BioNexus Gene Lab Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 17.8M shares, a 12.2% increase from 2023.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)